INC.;REATA PHARMACEUTICALS;TRUSTEES OF DARTMOUTH COLLEGE;REATA PHARMACEUTICALS, INC.
发明人:
Michael B. SPORN,Karen T. LIBY,Gordon W. GRIBBLE,Tadashi HONDA,Robert M. KRAL,Colin J. MEYER
申请号:
US13886053
公开号:
US20130345276A1
申请日:
2013.05.02
申请国别(地区):
US
年份:
2013
代理人:
摘要:
The present invention concerns methods for treating and preventing renal/kidney disease, insulin resistance/diabetes, fatty liver disease, and/or endothelial dysfunction/cardiovascular disease using synthetic triterpenoids, optionally in combination with a second treatment or prophylaxis.